These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32918970)

  • 1. Integrating cullin2-RING E3 ligase as a potential biomarker for glioblastoma multiforme prognosis and radiosensitivity profiling.
    Zheng S; Wu Y; Li Z
    Radiother Oncol; 2021 Jan; 154():36-44. PubMed ID: 32918970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A functional artificial neural network for noninvasive pretreatment evaluation of glioblastoma patients.
    Zander E; Ardeleanu A; Singleton R; Bede B; Wu Y; Zheng S
    Neurooncol Adv; 2022; 4(1):vdab167. PubMed ID: 35059640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a cullin5-RING E3 ligase transcriptome signature in glioblastoma multiforme.
    Zheng S; Li Z
    Aging (Albany NY); 2020 Sep; 12(17):17380-17392. PubMed ID: 32931454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atlas on substrate recognition subunits of CRL2 E3 ligases.
    Wang S; Xia W; Qiu M; Wang X; Jiang F; Yin R; Xu L
    Oncotarget; 2016 Jul; 7(29):46707-46716. PubMed ID: 27107416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
    Liang Y; Bollen AW; Aldape KD; Gupta N
    BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrative characterization of recurrent molecular aberrations in glioblastoma genomes.
    Sintupisut N; Liu PL; Yeang CH
    Nucleic Acids Res; 2013 Oct; 41(19):8803-21. PubMed ID: 23907387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gelsolin knockdown confers radiosensitivity to glioblastoma cells.
    Gao D; Jiang T; Liu Y
    Cancer Med; 2024 May; 13(10):e7286. PubMed ID: 38803199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioblastoma Multiforme: Fewer Tumor Copy Number Segments of the
    Lehrer S; Rheinstein PH; Rosenzweig KE
    Cancer Genomics Proteomics; 2018; 15(4):273-278. PubMed ID: 29976632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma.
    Jeong HY; Kim HJ; Kim CE; Lee S; Choi MC; Kim SH
    Int J Neurosci; 2021 Jan; 131(1):7-14. PubMed ID: 32075484
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of Novel Transcriptome Signature as a Potential Prognostic Biomarker for Anti-Angiogenic Therapy in Glioblastoma Multiforme.
    Zheng S; Tao W
    Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33804433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme.
    Quan AL; Barnett GH; Lee SY; Vogelbaum MA; Toms SA; Staugaitis SM; Prayson RA; Peereboom DM; Stevens GH; Cohen BH; Suh JH
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):695-703. PubMed ID: 15936158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and External Validation of a Hypoxia-Derived Gene Signature for Robustly Predicting Prognosis and Therapeutic Responses in Glioblastoma Multiforme.
    Wang K; Lu Y; Liu Z; Diao M; Yang L
    Biomed Res Int; 2022; 2022():7858477. PubMed ID: 35155681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E3 ligase MAEA-mediated ubiquitination and degradation of PHD3 promotes glioblastoma progression.
    Zhou P; Peng X; Tang S; Zhang K; Tan Z; Li D; Shen L; Peng J; Yang L
    Oncogene; 2023 Apr; 42(16):1308-1320. PubMed ID: 36882523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of glioblastoma by targeting the overactivated protein neddylation pathway.
    Hua W; Li C; Yang Z; Li L; Jiang Y; Yu G; Zhu W; Liu Z; Duan S; Chu Y; Yang M; Zhang Y; Mao Y; Jia L
    Neuro Oncol; 2015 Oct; 17(10):1333-43. PubMed ID: 25904638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polo‑like kinase 4 promotes tumorigenesis and induces resistance to radiotherapy in glioblastoma.
    Wang J; Zuo J; Wang M; Ma X; Gao K; Bai X; Wang N; Xie W; Liu H
    Oncol Rep; 2019 Apr; 41(4):2159-2167. PubMed ID: 30816483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GSVD comparison of patient-matched normal and tumor aCGH profiles reveals global copy-number alterations predicting glioblastoma multiforme survival.
    Lee CH; Alpert BO; Sankaranarayanan P; Alter O
    PLoS One; 2012; 7(1):e30098. PubMed ID: 22291905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ID1 affects the efficacy of radiotherapy in glioblastoma through inhibition of DNA repair pathways.
    Guo Q; Guo P; Mao Q; Lan J; Lin Y; Jiang J; Qiu Y
    Med Oncol; 2013 Mar; 30(1):325. PubMed ID: 23377983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of TMEM59L associated with radiosensitive in glioblastoma.
    Gao D; Wang P; Zhi L; Sun S; Qiu X; Liu Y
    J Radiat Res; 2023 Sep; 64(5):833-841. PubMed ID: 37439405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells.
    Maachani UB; Shankavaram U; Kramp T; Tofilon PJ; Camphausen K; Tandle AT
    Oncotarget; 2016 Nov; 7(47):77365-77377. PubMed ID: 27764801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
    Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
    Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.